EL
GSK icon

EMFO LLC’s GSK GSK Stock Holding History

EMFO LLC’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$17.3K Hold
449
– – 0.02% 200
2024
Q1 		$19.2K Hold
449
– – 0.02% 198
2023
Q4 		$16.6K Hold
449
– – 0.02% 203
2023
Q3 		$16.3K Hold
449
– – 0.02% 209
2023
Q2 		$16K Hold
449
– – 0.01% 219
2023
Q1 		$16K Hold
449
– – 0.02% 223
2022
Q4 		$15.8K Hold
449
– – 0.02% 213
2022
Q3 		$13K Sell
449
-885
-66% -$33.5K 0.01% 242
2022
Q2 		$73K Hold
1,334
– – 0.07% 155
2022
Q1 		$73K Hold
1,334
– – 0.07% 172
2021
Q4 		$74K Hold
1,334
– – 0.07% 169
2021
Q3 		$64K Buy
1,334
+1,254
+1,568% +$63K 0.06% 183
2021
Q2 		$4K Buy
+80
New +$3.84K ﹤0.01% 316

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

EMFO LLC's GSK Position: Q2 2024 in Review

EMFO LLC held its GSK (GSK) position steady in Q2 2024 at 449 shares worth $17.3K. The position accounts for 0.02% of the portfolio, ranked #200.

EMFO LLC first reported a position in GSK in Q2 2021 and has held it in 13 quarters since. The position peaked at $74K in Q4 2021. 884 funds tracked by Wall St. Rank hold GSK as of Q2 2024.

  • EMFO LLC held 449 shares of GSK worth $17.3K as of Q2 2024.
  • EMFO LLC left its GSK share count unchanged in Q2 2024.
  • GSK made up 0.02% of EMFO LLC's portfolio in Q2 2024, its #200 holding.
  • EMFO LLC first reported a position in GSK in Q2 2021 and has held it in 13 quarters since.
  • EMFO LLC's GSK position peaked at $74K in Q4 2021.
  • 884 funds tracked by Wall St. Rank held GSK as of Q2 2024.

Based on EMFO LLC's 13F filing for Q2 2024, filed 26 Jul 2024.